The factsheet has been successfully sent.
Please check your inbox.
Please fill in the form to receive the factsheet directly into your inbox

You have items in your inquiry list.
Inquire now?

21 July 2022 [Press release]

Improved performance of GenoImmu™ COVID-19 Antigen Detection Kit

DiagCor Life Science is happy to report improved performance of our CE-IVD marked GenoImmuTM COVID-19 Antigen Detection Kit.

● Rapid – Result in 15-20 minutes
● Accurate – Sensitivity ≥ 96%, Specificity ≥ 99%

In addition, the kit is able to detect SARS-CoV-2 variants such as Delta and Omicron.

Please see our product page or contact us directly for more details.

About DiagCor

Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.

Press Contact

DiagCor Life Science

[email protected]